Taken all together, our results indicated that RIT1 inhibited tumor tumorigenesis and metastasis via inhibiting MAPK and PI3K/AKT pathways and EMT in ESCC, respectively. This evidence concerns the gene RIT1 and esophageal squamous cell carcinoma.